mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.001 |
mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
-0.17 |
0.001 |
mRNA |
BRD-K55116708 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.002 |
mRNA |
ML006 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.004 |
mRNA |
BRD1835 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.004 |
mRNA |
chlorambucil |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.004 |
mRNA |
AZ-3146 |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.005 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.006 |